CBI is an investment company that focuses on Israeli-related targets in the healthcare and biotechnology sectors.

Clal Biotechnology Industries (TASE: CBI) is a leading Israeli life sciences investment company. It identifies and supports promising innovative ventures with proprietary solutions to unmet medical needs. CBI holds and manages an international portfolio of some fifteen biotechnology and medical device companies.

Clal Biotechnology Industries

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It invests between $0.5 million and $10 million per company. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional office in Cambridge, Massachusetts. It operates as a former subsidiary of Clal Industries and Investments Ltd.

CBI

IL:CO:CBI

CBI

Last Close

35.20

21/11 15:24

Market Cap

71.36M

Beta: -

Volume Today

117.52K

Avg: -

Analysis Not Available